Clinical trials: Hospitalized Patients
Community Acquired Pneumonia
A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of China
The purpose of this study is to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China
- Trial name
- CAP-China (NCT02492425)
- Where
- China
- Volunteers
- 3,000 people
- Sponsor
- Capital Medical University
Peritonitis
Post Surgically Treated Peritonitis Complications
The purpose of this observational study is to investigate the management and the complications associated wtih surgically treated peritonitis.
- Trial name
- NCT03284476
- Testing
- Collection of medical data from ICU patients
- Where
- 5 sites in France
- Sponsor
- Nantes University Hospital
COVID, Infectious Disease
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
In this study, investigators will determine whether the early addition of HT-CCP to standard treatment improves the clinical outcome (as assessed by the Modified WHO Ordinal Scale) of patients with COVID-19 who are hospitalized…
- Trial name
- (ESCAPE) (NCT04361253)
- Testing
- High-Titer COVID-19 Convalescent Plasma (HT-CCP), Standard Plasma (FFP)
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- Brigham and Women's Hospital
Coronavirus
Dexamethasone and COVID-19 Inpatient Mortality
The study aims to assess the effectiveness of dexamethasone initiation to reduce the risk of inpatient mortality within 28 days among US patients hospitalized with COVID-19 diagnosis or SARS-CoV-2 infection, overall and…
- Trial name
- NCT04926571
- Testing
- Dexamethasone Oral
- Where
- United States
- Volunteers
- 14,105 people
- Sponsor
- Aetion, Inc.
Advanced Solid Tumors Cancer, Hospitalizations
Biological Age Predicts 90-Day Mortality in Advanced Cancer
This retrospective study evaluates whether biological age, calculated using the PhenoAge model, predicts short-term outcomes in patients with advanced cancer who were hospitalized.
- Trial name
- BIOAGE-CAN (NCT07035470)
- Testing
- PhenoAge-Based Biological Age Assessment
- Where
- Turkey (Türkiye)
- Volunteers
- 1,615 people
- Sponsor
- Ankara Etlik City Hospital
Liver Injury
Liver Injury in Patients With COVID-19
Coronavirus disease was first diagnosed in December 2019, in the city of Wuhan, China. The World Health Organization recently declared coronavirus disease 2019 (COVID-19) as a pandemic.
- Trial name
- NCT04358380
- Testing
- Liver injury
- Where
- Argentina
- Volunteers
- 320 people
- Sponsor
- Austral University, Argentina
COVID-19
The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19
The coronavirus disease 2019 (COVID-19) has spread rapidly and caused a global pandemic, as defined by the WHO, within a short period of time.
- Trial name
- LUSZ_SCORE (NCT05848427)
- Testing
- LUSZ P
- Where
- 2 sites in Lebanon
- Volunteers
- 1,000 people
- Sponsor
- Lebanese University
Medication Safety, Preventable Medication Harm
Clinical Pharmacist Impact Study
This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify…
- Conditions
- Medication Safety, Preventable Medication Harm, Pharmacotherapy Optimization
- Trial name
- NCT07269002
- Testing
- Pharmacist-Led Medication Safety Program
- Where
- Egypt
- Volunteers
- 3,600 people
- Sponsor
- Beni-Suef University
Pulmonary Disease, Chronic Obstructive, Heart Failure
Self-care Program in the Prevention of Admissions of Patients
One of the most cost effective intervention is to avoid unnecessary hospitalizations in the national health system. These unnecessary admissions are increasing for several years, reaching rates of over 30% in patients with…
- Trial name
- AUTOCUID (NCT01726244)
- Testing
- Multidisciplinary Intervention
- Where
- Spain
- Volunteers
- 144 people
- Sponsor
- Basque Health Service
Bronchiolitis, Bronchiolitis Acute Viral
Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age
Medical practice variability refers to differences in treatment and clinical outcomes that cannot be solely explained by patient characteristics or medical conditions.
- Trial name
- NCT07202585
- Where
- Argentina
- Volunteers
- 127 people
- Sponsor
- Hospital General de Niños Pedro de Elizalde
Candida Infection
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
Bloodstream infections due to Candida spp remain a serious medical challenge because of their high incidence and poor outcome. Diagnosis and monitoring of patients are still problematic, hindering efficient clinical management of…
- Trial name
- 2419 (NCT05720728)
- Testing
- collection of blood samples
- Where
- Italy
- Volunteers
- 50 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fulminating Hepatic Failure
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
The main objective is to determine the medical fate (transplanted or not and living or deceased), of patients with Severe, fulminating acute liver failure in the public hospitals of paris.
- Trial name
- DEVINHEF (NCT04658407)
- Where
- France
- Volunteers
- 18,000 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
COVID-19 SARS-CoV-2 Infection
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease.
- Trial name
- NCT06679140
- Testing
- ibuzatrelvir
- Where
- 256 sites in United States, Argentina and 17 more
- Volunteers
- 2,330 people
- Sponsor
- Pfizer
Healthcare-Associated Infections (HAIs), Nosocomial Infection
Easy Hands: Impact of a 3-Step Versus WHO 6-Step Hand Hygiene Technique on Healthcare-Associated Infections in Intensive Care and Hospitalization Units.
Healthcare-associated infections (HAIs) remain a major cause of morbidity, mortality, and healthcare costs worldwide. Hand hygiene is the cornerstone of infection prevention; however, adherence to the full WHO 6-step hand hygiene…
- Trial name
- EASY HANDS (NCT07593417)
- Testing
- 3-Step Hand Hygiene Technique, WHO 6-Step Hand Hygiene Technique
- Where
- Colombia
- Volunteers
- 1,027 people
- Sponsor
- Fundación Clínica Shaio
Coronavirus
At Home Monitoring for Patients With Covid19
The vast majority of individuals with Covid19 have mild illness that can be managed in the outpatient setting. A small but significant number of these people will deteriorate and require hospitalization.
- Trial name
- NCT04453774
- Testing
- Covidfree@home
- Where
- 2 sites in Canada
- Volunteers
- 432 people
- Sponsor
- University Health Network, Toronto
Fluid Therapy
Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients
The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death…
- Trial name
- FLUID (NCT04512950)
- Testing
- Ringer's lactate, 0.9% saline
- Where
- 7 sites in Canada
- Volunteers
- 43,626 people
- Sponsor
- Ottawa Hospital Research Institute